Ado-Trastuzumab Emtansine Biosimilar - Research Grade

Product Sizes

5 mg

£1028.00

ICH4014-5MG

25 mg

£2738.00

ICH4014-25MG

200 mg

£6490.00

ICH4014-200MG

500 mg

£10536.00

ICH4014-500MG

1 g

£15789.00

ICH4014-1G

About this Product

SKU:: ICH4014
Additional Names:: Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu
CE/IVD:: RUO
Clonality:: Recombinant Monoclonal
Concentration:: 1-5 mg/ml
Extra Details:: Ado-trastuzumab emtansine is a HER2-targeted antibody-drug conjugate which contains the humanized anti-HER2 IgG1, trastuzumab, covalently linked to the microtubule inhibitory drug DM1 via the stable thioether linker MCC. Trastuzumab is produced by Chinese hamster ovary cells, and DM1-MCC are produced by chemical synthesis. Ado-trastuzumab emtansine contains an average of 3.5 DM1 molecules per antibody.
Formulation:: Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Host:: Human
Immunogen:: HER2
Isotype:: IgG1
Purity:: >95%
Purification:: Protein A/G Purified
Reactivities:: Human
Shipping Conditions:: Blue Ice
Specificity:: Detects human HER2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ado-trastuzumab emtansine.
Storage Conditions:: 2-8[o]C Aliquot. Avoid freeze/thaw cycles., -70[o]C Aliquot. Avoid freeze/thaw cycles.
Supplier:: ichorbio
Type:: Antibody: Biosimilar Antibody
Shipping Costs:: Free shipping to UK Customers

Basket